Skip to records

People

362Aging Biotech
100 of 362 records

Boris Djordjevic

Source date not recordedAnalyse record ↗

Founder and CEO of 199 Biotechnologies (199.bio), 199 Clinic, and The Continuum Clinic. Pioneer in partial reprogramming therapies for cancer and aging. 15+ years in ageing research and autologous treatments. Scientific advisors include João Pedro de Magalhães (University of Birmingham). Company focuses on mRNA delivery, cell therapy, organ-on-a-chip, and senolytic compounds (e.g., PCC1). Based in London, UK.

Sort name
Djordjevic, Boris
Affiliation
199 Biotechnologies / 199 Bio / 199 Clinic / The Continuum Clinic
Focus area
Partial reprogramming, epigenetic reprogramming, longevity diagnostics, gene therapies, cancer reprogramming, polyphenols research
Deceased
no
Roles
Founder, CEO

Founded (1)

199 Bio· Founded 199 Biotechnologies / 199 Bio